Cargando…

NSCLC as the Paradigm of Precision Medicine at Its Finest: The Rise of New Druggable Molecular Targets for Advanced Disease

Standard treatment for advanced non-small cell lung cancer (NSCLC) historically consisted of systemic cytotoxic chemotherapy until the early 2000s, when precision medicine led to a revolutionary change in the therapeutic scenario. The identification of oncogenic driver mutations in EGFR, ALK and ROS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michelotti, Anna, de Scordilli, Marco, Bertoli, Elisa, De Carlo, Elisa, Del Conte, Alessandro, Bearz, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223783/ https://www.ncbi.nlm.nih.gov/pubmed/35743191 http://dx.doi.org/10.3390/ijms23126748

Ejemplares similares

Targeted Therapy and Immunotherapy in Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Ongoing Trials
por: de Scordilli, Marco, et al.
Publicado: (2022)

The Change in Paradigm for NSCLC Patients with EML4–ALK Translocation
por: Bearz, Alessandra, et al.
Publicado: (2022)

Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications
por: Bertoli, Elisa, et al.
Publicado: (2023)

Bone Metastasis and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Microenvironment and Possible Clinical Implications
por: Del Conte, Alessandro, et al.
Publicado: (2022)

Emergency medicine: the finest hour in our time
por: Bobrow, Bentley J., et al.
Publicado: (2020)

Therapeutical Options in ROS1—Rearranged Advanced Non Small Cell Lung Cancer
por: Stanzione, Brigida, et al.
Publicado: (2023)

Brain Metastases Management in Oncogene-Addicted Non-Small Cell Lung Cancer in the Targeted Therapies Era
por: De Carlo, Elisa, et al.
Publicado: (2022)

Acquired Resistance to Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer: How Do We Overcome It?
por: Bertoli, Elisa, et al.
Publicado: (2022)

Ectatic Coronary Arteries: Diversity at Its Finest
por: Belharty, Najlaa, et al.
Publicado: (2023)

Targeted therapies in melanoma: Translational research at its finest
por: Ho, Allen W., et al.
Publicado: (2015)

The Story of the Finest Armor: Developmental Aspects of Reptile Skin
por: Yenmiş, Melodi, et al.
Publicado: (2023)

Structural and wetting properties of nature's finest silks (order Embioptera)
por: Stokes, Grace Y., et al.
Publicado: (2018)

Commentary: Finding a solution to the problem: Innovation at its finest
por: Pagani, Francis D.
Publicado: (2021)

Differences in local population history at the finest level: the case of the Estonian population
por: Pankratov, Vasili, et al.
Publicado: (2020)

Precise druggability of the PTH type 1 receptor
por: Sutkeviciute, Ieva, et al.
Publicado: (2022)

Human Health Risk Assessment associated with contaminants in the finest fraction of sidewalk dust collected in proximity to trafficked roads
por: Adamiec, Ewa, et al.
Publicado: (2019)

Precision Medicine: A New Paradigm in Therapeutics
por: Akhoon, Neha
Publicado: (2021)

The finest instruments ever made: a bibliography of medical, dental, optical and pharmaceutical company trade literature, 1700–1939
por: Lawrence, Ghislaine M.
Publicado: (1989)

Precision Medicine in Neurology: The Inspirational Paradigm of Complement Therapeutics
por: Gavriilaki, Maria, et al.
Publicado: (2020)

Precision Surgery in NSCLC
por: Cannone, Giorgio, et al.
Publicado: (2023)

Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient
por: Rossi, Giovanni, et al.
Publicado: (2020)

Future Roadmaps for Precision Medicine Applied to Diabetes: Rising to the Challenge of Heterogeneity
por: Bowman, P., et al.
Publicado: (2018)

NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome
por: Michelotti, Anna, et al.
Publicado: (2021)

Editorial: Rising stars in precision medicine 2021: imprecise medicine is unethical in the big data era
por: Liebeskind, David S.
Publicado: (2023)

Outcomes of ALK positive lung cancer patients treated with crizotinib or second-generation ALK inhibitor: a monoinstitutional experience
por: De Carlo, Elisa, et al.
Publicado: (2018)

Rise of Deep Learning for Genomic, Proteomic, and Metabolomic Data Integration in Precision Medicine
por: Grapov, Dmitry, et al.
Publicado: (2018)

Changing paradigm of cancer therapy: precision medicine by next-generation sequencing
por: Xue, Yuan, et al.
Publicado: (2016)

Collaborative Paradigm of Preventive, Personalized, and Precision Medicine With Point-of-Care Technologies
Publicado: (2016)

The fourth scientific discovery paradigm for precision medicine and healthcare: Challenges ahead
por: Shen, Li, et al.
Publicado: (2021)

CRISPR based therapeutics: a new paradigm in cancer precision medicine
por: Das, Sumit, et al.
Publicado: (2022)

Toward precision medicine in myotonic syndromes
por: De Bellis, Michela, et al.
Publicado: (2017)

Updating the Targeted Therapy Paradigm for Patients With Metastatic NSCLC
por: Florez (DUMA), Narjust, et al.
Publicado: (2023)

Activity of crizotinib over choroidal metastases in Non-Small-Cell Lung Cancer (NSCLC)-ALK rearranged: a case report
por: Bearz, Alessandra, et al.
Publicado: (2014)

Concurrent chemoradiotherapy with tomotherapy in locally advanced non-small cell lung cancer: a phase i, docetaxel dose-escalation study, with hypofractionated radiation regimen
por: Bearz, Alessandra, et al.
Publicado: (2013)

The Druggable Pocketome of Corynebacterium diphtheriae: A New Approach for in silico Putative Druggable Targets
por: Hassan, Syed S., et al.
Publicado: (2018)

Phenomic Microglia Diversity as a Druggable Target in the Hippocampus in Neurodegenerative Diseases
por: Lana, Daniele, et al.
Publicado: (2023)

Future paradigms for precision oncology
por: Klement, Giannoula Lakka, et al.
Publicado: (2016)

Precision Medicine: An Emerging Paradigm for Improved Diagnosis and Safe Therapy in Pediatric Oncology
por: Singla, Puneet, et al.
Publicado: (2021)

Use of Apolipoprotein B in the Era of Precision Medicine: Time for a Paradigm Change?
por: Cole, Justine, et al.
Publicado: (2023)

KRAS: Druggable at Last
por: Herzberg, Benjamin O, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kilb64ihmfg4n65vh7n5ets55e